+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

Interleukin 8 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 8 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-12 expression stimulants - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-12 expression stimulants - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin 6 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 6 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
Interleukin-33 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-33 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin 1 beta inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 1 beta inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
KEVZARA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEVZARA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Tadekinig Alfa - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Tadekinig Alfa - Emerging Insight and Market Forecast - 2030

  • Report
  • April 2021
  • 35 Pages
  • Global
From
Ilaris - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ilaris - Drug Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more